Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Change in Receivables (2017 - 2019)

enVVeno Medical has reported Change in Receivables over the past 3 years, most recently at -$26515.0 for Q2 2019.

  • For Q2 2019, Change in Receivables fell 1162.02% year-over-year to -$26515.0; the TTM value through Dec 2019 reached -$32022.0, down 913.68%, while the annual FY2019 figure was -$32022.0, 913.68% down from the prior year.
  • Change in Receivables for Q2 2019 was -$26515.0 at enVVeno Medical, down from -$5507.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $7301.0 in Q4 2017 and troughed at -$26515.0 in Q2 2019.
  • A 3-year average of -$4850.0 and a median of -$3108.5 in 2018 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: skyrocketed 91.74% in 2018 and later tumbled 1162.02% in 2019.
  • Year by year, Change in Receivables stood at $7301.0 in 2017, then tumbled by 45.76% to $3960.0 in 2018, then tumbled by 769.57% to -$26515.0 in 2019.
  • Business Quant data shows Change in Receivables for NVNO at -$26515.0 in Q2 2019, -$5507.0 in Q1 2019, and $3960.0 in Q4 2018.